A double-blind, placebo-controlled study published in Psychopharmacology showed that menopausal women who took lisdexamfetamine showed improvement in both subjective and objective measures of cognitive decline that are often experienced at menopause. [More…]
- Activities▼
- Education Hubs▼
-
- Alzheimer’s Disease
- Cardiology
- COVID-19
- Dermatology
- Diversity & Inclusion
- Gastroenterology
- Hematology
- Immunodeficiency Disorders
- Infectious Disease
- Liver Disease
- Migraine
- Multiple Sclerosis
- Neuropsychiatric
- Oncology
- Ophthalmology
- Opioid
- Pain Management
- Pediatrics
- Psoriatic Arthritis
- Rare Diseases
- Respiratory
- Rheumatology
- Sleep Disorders
- Virtual Education
-
- Services▼
- News▼
